(Q42225065)

English

Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus

scientific article published on 5 March 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

avian influenza

1 reference

based on heuristic

inferred from title

Jacqueline M. Katz

13

object named as

Jacqueline M Katz

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Terrence M Tumpey

14

object named as

Terrence M Tumpey

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Larisa Gubareva

7

object named as

Larisa V Gubareva

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

6

object named as

Vic Veguilla

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

Xiuhua Lu

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Feng Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hui Zeng

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Tiffany Sheu

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Jenna E Achenbach

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Rebecca Garten

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Catherine Smith

9

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hua Yang

10

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

James Stevens

11

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Xiyan Xu

12

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

0 references

publication date

5 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

454-455

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

169-175

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Antigenic, sequence, and crystal variation in influenza B neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Evaluation of a Neuraminidase-Specific Influenza A Virus Vaccine in Children: Antibody Responses and Effects on Two Successive Outbreaks of Natural Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

PyMod: sequence similarity searches, multiple sequence-structure alignments, and homology modeling within PyMOL

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Three-dimensional structure of a complex of antibody with influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Recombinant neuraminidase vaccine protects against lethal influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Influenza: the new acquayantance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Anti N1 cross-protecting antibodies against H5N1 detected in H1N1 infected people.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Serologic assays for influenza surveillance, diagnosis and vaccine evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Laboratory-based surveillance of influenza virus in the United States during the winter of 1977-1978. I. Periods of prevalence of H1N1 and H3N2 influenza A strains, their relative rates of isolation in different age groups, and detection of antigeni

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Protection of mice with recombinant influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Clustal W and Clustal X version 2.0

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Sequence of the neuraminidase gene of influenza virus A/Tokyo/3/67 and previously uncharacterized monoclonal variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Structural and functional characterization of neuraminidase-like molecule N10 derived from bat influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Effect of neuraminidase antibody on Hong Kong influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

The significance of influenza virus neuraminidase in immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Functional significance of sialidose during influenza virus multiplication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Antigenic variability in Neuraminidase protein of Influenza A/H3N2 vaccine strains (1968 - 2009).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Natural infection with influenza A (H3N2). The development, persistence and effect of antibodies to the surface antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Characterization of the reconstructed 1918 Spanish influenza pandemic virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Influenza A Virus N5 Neuraminidase Has an Extended 150-Cavity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Protection against lethal influenza with neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Structural basis of immune recognition of influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

A Virus Obtained from Influenza Patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

based on heuristic

inferred from DOI database lookup

A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic variation in neuraminidase genes of influenza A (H3N2) viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.011

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2014.02.011

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42225065&oldid=1937068267"